| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75.6M | — | -21.3% |
| R&D Expense | $3.7M | — | +1.8% |
| SG&A Expense | $30.8M | — | -6.3% |
| Operating Income | -$18.7M | — | -33.7% |
| Pre-tax Income | -$16.7M | — | -12.7% |
| Income Tax | $19K | — | +100.5% |
| Net Income | -$14.8M | — | -57.0% |
| EPS (Basic) | -$0.15 | — | -66.7% |
| EPS (Diluted) | -$0.15 | — | -66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.7M | -30.1% | -54.8% |
| Accounts Receivable | $94.0M | +1.2% | -47.4% |
| Current Assets | $138.2M | -9.3% | -47.4% |
| Total Assets | $209.2M | -3.6% | -51.4% |
| Current Liabilities | $77.2M | +14.4% | -28.2% |
| Long-term Debt | $221K |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | -148.2% |
| Capital Expenditures | $430K | — | -70.7% |
| Investing Cash Flow | $1.7M | — | +128.9% |
| Financing Cash Flow | -$2.5M | — | +71.1% |
| Free Cash Flow | -$5.1M | — | -162.1% |
| +1364.9% |
| Total Liabilities | $98.0M | +7.4% | -23.9% |
| Stockholders' Equity | $132.3M | -8.1% | -57.2% |